Neuromuscular blockade: Is it still useful in the ICU?

European Journal of Anaesthesiology, Supplement

Volumn 128, Issue 5, 1997, Pages 53-56

  Meistelman, C ^a   Plaud, B ^b  

^a CHU NANCY BRABOIS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Intensive care; Monitoring, neuromuscular function; Neuromuscular relaxants, nerve, polyneuropathy; Neuromuscular transmission, stimulator, nerve

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

ARTICLE; HUMAN; INTENSIVE CARE UNIT; NEUROMUSCULAR BLOCKING; TIME;

HUMANS; INTENSIVE CARE UNITS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; TIME FACTORS;

EID: 0031131835     PISSN: 09521941     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bion JF, Ledingham JI. Sedation in intensive care - a postal survey. Intensive Care Med 1987; 13: 215-216.
2. Klessig HT, Geiger HJ, Murray MJ, Coursin DB. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992; 20: 1341-1345.
3. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991; 266: 2870-2875.
4. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992; 102: 510-514.
5. Miller RD. Use of neuromuscular blocking drugs in intensive care unit patients. Anesth Analg 1995; 81:1-2.
6. Yate PM, Flynn PM, Arnold RW, Weatherley B, Simmonds RJ, Dopson T. Clinical experience and plasma laudanosine concentrations during atracurium infusion in the intensive therapy unit. Br J Anaesth 1987; 59: 211-217.
7. Op de Coul AAW, Lambregts PCLA, Koeman J, van Puyenbroek MJE, Ter Laak HJ, Gabreels-Festen AAWM. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985; 87: 17-22.
8. Segredo V, Caldwell JE, Matthay M, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524-528.
9. Prielipp RC, Coursin DB, Scuderi PE et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81: 3-12.
10. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology 1990; 73: 870-875.
11. Hogue CW, Ward JM, Itani S, Martyn JAJ. Tolerance and upregulation of acetylcholine receptors following chronic infusion of d-tubocurarine. J Appl Physiol 1992; 72: 1326-1331.
12. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 19: 1125-1131.
13. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78: 772-774.